Immunogenicity of β-cells for autologous transplantation in type 1 diabetes

Pharmacological Research

Volumn 98, Issue , 2015, Pages 60-68

  Schuetz, Christian ^a   Markmann, James F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Immune tolerance; Immunogenicity; Induced pluripotent stem cells; Islet transplantation; Pancreatic beta cells; Type 1 diabetes mellitus

Indexed keywords

ABATACEPT; IMMUNOSUPPRESSIVE AGENT; INSULIN DERIVATIVE; THYMOCYTE ANTIBODY;

ARTICLE; AUTOIMMUNITY; AUTOTRANSPLANTATION; CARCINOGENICITY; CELL DIFFERENTIATION; CELL ENCAPSULATION; CELL TRANSPLANTATION; EMBRYONIC STEM CELL; GLYCEMIC CONTROL; HLA TYPING; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; NONHUMAN; NUCLEAR REPROGRAMMING; PANCREAS ISLET BETA CELL; PANCREATIC BETA CELL TRANSPLANTATION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RECURRENT DISEASE; TERATOMA; ANIMAL; DIABETES MELLITUS, TYPE 1; IMMUNOLOGY; PANCREAS ISLET TRANSPLANTATION; TRANSPLANTATION;

ANIMALS; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS TRANSPLANTATION; PLURIPOTENT STEM CELLS; TRANSPLANTATION, AUTOLOGOUS;

EID: 84930764050     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2015.03.003     Document Type: Review

References (118)

1. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (ukpds 34). Uk prospective diabetes study (ukpds) group Lancet 352 1998 854 865
2. S. Genuth, R. Eastman, R. Kahn, R. Klein, J. Lachin, H. Lebovitz, D. Nathan, and F. Vinicor American Diabetes A. Implications of the united kingdom prospective diabetes study Diabetes Care 26 Suppl. 1 2003 S28 S32
3. D.M. Nathan, P.A. Cleary, J.Y. Backlund, S.M. Genuth, J.M. Lachin, T.J. Orchard, P. Raskin, and B. Zinman Diabetes C, Complications Trial/Epidemiology of Diabetes I, Complications Study Research G. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes N. Engl. J. Med. 353 2005 2643 2653
4. E.W. Gregg, Y.J. Cheng, S. Saydah, C. Cowie, S. Garfield, L. Geiss, and L. Barker Trends in death rates among U.S. Adults with and without diabetes between 1997 and 2006: findings from the national health interview survey Diabetes Care 35 2012 1252 1257
5. S.J. Livingstone, H.C. Looker, E.J. Hothersall, S.H. Wild, R.S. Lindsay, J. Chalmers, S. Cleland, G.P. Leese, J. McKnight, A.D. Morris, D.W. Pearson, N.R. Peden, J.R. Petrie, S. Philip, N. Sattar, F. Sullivan, and H.M. Colhoun Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study PLoS Med. 9 2012 e1001321
6. M. Lind, A.M. Svensson, M. Kosiborod, S. Gudbjornsdottir, A. Pivodic, H. Wedel, S. Dahlqvist, M. Clements, and A. Rosengren Glycemic control and excess mortality in type 1 diabetes N. Engl. J. Med. 371 2014 1972 1982
7. C.J. Orr, W. Hopman, J.L. Yen, and R.L. Houlden Long-term efficacy of insulin pump therapy on glycemic control in adults with type 1 diabetes mellitus Diabetes Technol. Ther. 17 2015 49 54
8. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study G, B. Bode, R.W. Beck, D. Xing, L. Gilliam, I. Hirsch, C. Kollman, L. Laffel, K.J. Ruedy, W.V. Tamborlane, S. Weinzimer, and H. Wolpert Sustained benefit of continuous glucose monitoring on a1c, glucose profiles, and hypoglycemia in adults with type 1 diabetes Diabetes Care 32 2009 2047 2049
9. H.C. Yeh, T.T. Brown, N. Maruthur, P. Ranasinghe, Z. Berger, Y.D. Suh, L.M. Wilson, E.B. Haberl, J. Brick, E.B. Bass, and S.H. Golden Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis Ann. Intern. Med. 157 2012 336 347
10. T. Peyser, E. Dassau, M. Breton, and J.S. Skyler The artificial pancreas: current status and future prospects in the management of diabetes Ann. N.Y. Acad. Sci. 1311 2014 102 123
11. S.J. Russell, F.H. El-Khatib, M. Sinha, K.L. Magyar, K. McKeon, L.G. Goergen, C. Balliro, M.A. Hillard, D.M. Nathan, and E.R. Damiano Outpatient glycemic control with a bionic pancreas in type 1 diabetes N. Engl. J. Med. 371 2014 313 325
12. A.C. Gruessner, and D.E. Sutherland Pancreas transplant outcomes for united states (us) cases reported to the united network for organ sharing (unos) and non-us cases reported to the international pancreas transplant registry (iptr) as of october, 2000 Clin. Transpl. 2000 45 72
13. A.M. Shapiro, J.R. Lakey, E.A. Ryan, G.S. Korbutt, E. Toth, G.L. Warnock, N.M. Kneteman, and R.V. Rajotte Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen N. Engl. J. Med. 343 2000 230 238
14. G.L. Warnock, D.M. Thompson, R.M. Meloche, R.J. Shapiro, Z. Ao, P. Keown, J.D. Johnson, C.B. Verchere, N. Partovi, I.S. Begg, M. Fung, S.E. Kozak, S.O. Tong, K.M. Alghofaili, and C. Harris A multi-year analysis of islet transplantation compared with intensive medical therapy on progression of complications in type 1 diabetes Transplantation 86 2008 1762 1766
15. C.B. Leitao, T. Tharavanij, P. Cure, A. Pileggi, D.A. Baidal, C. Ricordi, and R. Alejandro Restoration of hypoglycemia awareness after islet transplantation Diabetes Care 31 2008 2113 2115
16. A.M. Shapiro, C. Ricordi, B.J. Hering, H. Auchincloss, R. Lindblad, R.P. Robertson, A. Secchi, M.D. Brendel, T. Berney, D.C. Brennan, E. Cagliero, R. Alejandro, E.A. Ryan, B. DiMercurio, P. Morel, K.S. Polonsky, J.A. Reems, R.G. Bretzel, F. Bertuzzi, T. Froud, R. Kandaswamy, D.E. Sutherland, G. Eisenbarth, M. Segal, J. Preiksaitis, G.S. Korbutt, F.B. Barton, L. Viviano, V. Seyfert-Margolis, J. Bluestone, and J.R. Lakey International trial of the edmonton protocol for islet transplantation N. Engl. J. Med. 355 2006 1318 1330
17. F.B. Barton, M.R. Rickels, R. Alejandro, B.J. Hering, S. Wease, B. Naziruddin, J. Oberholzer, J.S. Odorico, M.R. Garfinkel, M. Levy, F. Pattou, T. Berney, A. Secchi, S. Messinger, P.A. Senior, P. Maffi, A. Posselt, P.G. Stock, D.B. Kaufman, X. Luo, F. Kandeel, E. Cagliero, N.A. Turgeon, P. Witkowski, A. Naji, P.J. O'Connell, C. Greenbaum, Y.C. Kudva, K.L. Brayman, M.J. Aull, C. Larsen, T.W. Kay, L.A. Fernandez, M.C. Vantyghem, M. Bellin, and A.M. Shapiro Improvement in outcomes of clinical islet transplantation: 1999-2010 Diabetes Care 35 2012 1436 1445
18. E.A. Ryan, B.W. Paty, P.A. Senior, and A.M. Shapiro Risks and side effects of islet transplantation Curr. Diabetes Rep. 4 2004 304 309
19. N. Niclauss, D. Bosco, P. Morel, L. Giovannoni, T. Berney, and G. Parnaud Rapamycin impairs proliferation of transplanted islet beta cells Transplantation 91 2011 714 722
20. A.M. Posselt, G.L. Szot, L.A. Frassetto, U. Masharani, M. Tavakol, R. Amin, J. McElroy, M.D. Ramos, R.K. Kerlan, L. Fong, F. Vincenti, J.A. Bluestone, and P.G. Stock Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on t-cell adhesion or costimulation blockade Transplantation 90 2010 1595 1601
21. B.J. Hering, R. Kandaswamy, J.D. Ansite, P.M. Eckman, M. Nakano, T. Sawada, I. Matsumoto, S.H. Ihm, H.J. Zhang, J. Parkey, D.W. Hunter, and D.E. Sutherland Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes JAMA 293 2005 830 835
22. W. Bennet, C.G. Groth, R. Larsson, B. Nilsson, and O. Korsgren Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes Ups. J. Med. Sci. 105 2000 125 133
23. D.J. van der Windt, R. Bottino, G. Kumar, M. Wijkstrom, H. Hara, M. Ezzelarab, B. Ekser, C. Phelps, N. Murase, A. Casu, D. Ayares, F.G. Lakkis, M. Trucco, and D.K. Cooper Clinical islet xenotransplantation: how close are we Diabetes 61 2012 3046 3055
24. A. Rezania, J.E. Bruin, P. Arora, A. Rubin, I. Batushansky, A. Asadi, S. O'Dwyer, N. Quiskamp, M. Mojibian, T. Albrecht, Y.H. Yang, J.D. Johnson, and T.J. Kieffer Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells Nat. Biotechnol. 32 2014 1121 1133
25. O. Garkavenko, B. Dieckhoff, S. Wynyard, J. Denner, R.B. Elliott, P.L. Tan, and M.C. Croxson Absence of transmission of potentially xenotic viruses in a prospective pig to primate islet xenotransplantation study J. Med. Virol. 80 2008 2046 2052
26. R.S. Boneva, and T.M. Folks Xenotransplantation and risks of zoonotic infections Ann. Med. 36 2004 504 517
27. H.M. Tran, P.W. Nickerson, A. Patel, T.B. Strom, R.D.M. Allen, and P. O'Connell Short-term suppression of the xeno-immune response with mctla4-fc treatment Xenotransplantation 4 1997 222 227
28. B. Ekser, M. Ezzelarab, H. Hara, D.J. van der Windt, M. Wijkstrom, R. Bottino, M. Trucco, and D.K. Cooper Clinical xenotransplantation: the next medical revolution Lancet 379 2012 672 683
29. B.J. Hering, M. Wijkstrom, M.L. Graham, M. Hardstedt, T.C. Aasheim, T. Jie, J.D. Ansite, M. Nakano, J. Cheng, W. Li, K. Moran, U. Christians, C. Finnegan, C.D. Mills, D.E. Sutherland, P. Bansal-Pakala, M.P. Murtaugh, N. Kirchhof, and H.J. Schuurman Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates Nat. Med. 12 2006 301 303
30. K. Cardona, G.S. Korbutt, Z. Milas, J. Lyon, J. Cano, W. Jiang, H. Bello-Laborn, B. Hacquoil, E. Strobert, S. Gangappa, C.J. Weber, T.C. Pearson, R.V. Rajotte, and C.P. Larsen Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways Nat. Med. 12 2006 304 306
31. S. Yi, W.J. Hawthorne, A.M. Lehnert, H. Ha, J.K. Wong, N. van Rooijen, K. Davey, A.T. Patel, S.N. Walters, A. Chandra, and P.J. O'Connell T cell-activated macrophages are capable of both recognition and rejection of pancreatic islet xenografts J. Immunol. 170 2003 2750 2758
32. K. English, and K.J. Wood Immunogenicity of embryonic stem cell-derived progenitors after transplantation Curr. Opin. Organ Transpl. 16 2011 90 95
33. D.C. Wu, A.S. Boyd, and K.J. Wood Embryonic stem cells and their differentiated derivatives have a fragile immune privilege but still represent novel targets of immune attack Stem Cells 26 2008 1939 1950
34. M.D. Bellin, F.B. Barton, A. Heitman, J.V. Harmon, R. Kandaswamy, A.N. Balamurugan, D.E. Sutherland, R. Alejandro, and B.J. Hering Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes Am. J. Transpl. 12 2012 1576 1583
35. D.H. Sachs, T. Kawai, and M. Sykes Induction of tolerance through mixed chimerism Cold Spring Harb. Perspect. Med. 4 2014 a015529
36. T. Kawai, D.H. Sachs, B. Sprangers, T.R. Spitzer, S.L. Saidman, E. Zorn, N. Tolkoff-Rubin, F. Preffer, K. Crisalli, B. Gao, W. Wong, H. Morris, S.A. LoCascio, P. Sayre, B. Shonts, W.W. Williams Jr., R.N. Smith, R.B. Colvin, M. Sykes, and A.B. Cosimi Long-term results in recipients of combined hla-mismatched kidney and bone marrow transplantation without maintenance immunosuppression Am. J. Transpl. 14 2014 1599 1611
37. J.D. Scandling, S. Busque, S. Dejbakhsh-Jones, C. Benike, M.T. Millan, J.A. Shizuru, R.T. Hoppe, R. Lowsky, E.G. Engleman, and S. Strober Tolerance and chimerism after renal and hematopoietic-cell transplantation N. Engl. J. Med. 358 2008 362 368
38. S.I. Alexander, N. Smith, M. Hu, D. Verran, A. Shun, S. Dorney, A. Smith, B. Webster, P.J. Shaw, A. Lammi, and M.O. Stormon Chimerism and tolerance in a recipient of a deceased-donor liver transplant N. Engl. J. Med. 358 2008 369 374
39. T. Kawai, A.B. Cosimi, T.R. Spitzer, N. Tolkoff-Rubin, M. Suthanthiran, S.L. Saidman, J. Shaffer, F.I. Preffer, R. Ding, V. Sharma, J.A. Fishman, B. Dey, D.S. Ko, M. Hertl, N.B. Goes, W. Wong, W.W. Williams Jr., R.B. Colvin, M. Sykes, and D.H. Sachs Hla-mismatched renal transplantation without maintenance immunosuppression N. Engl. J. Med. 358 2008 353 361
40. Q. Tang, K.J. Henriksen, M. Bi, E.B. Finger, G. Szot, J. Ye, E.L. Masteller, H. McDevitt, M. Bonyhadi, and J.A. Bluestone In vitro-expanded antigen-specific regulatory t cells suppress autoimmune diabetes J. Exp. Med. 199 2004 1455 1465
41. D.R. Getts, D.P. McCarthy, and S.D. Miller Exploiting apoptosis for therapeutic tolerance induction J. Immunol. 191 2013 5341 5346
42. G.C. Weir Islet encapsulation: advances and obstacles Diabetologia 56 2013 1458 1461
43. K. Rahul, A. Michael, R. Lourdes, E.F. Clarence, and R.T.L. Jonathan Islet and stem cell encapsulation for clinical transplantation RDS 11 2014 84 101
44. D.W. Scharp, and P. Marchetti Encapsulated islets for diabetes therapy: history, current progress, and critical issues requiring solution Adv. Drug Deliv. Rev. 67/68 2014 35 73
45. B.E. Tuch, G.W. Keogh, L.J. Williams, W. Wu, J.L. Foster, V. Vaithilingam, and R. Philips Safety and viability of microencapsulated human islets transplanted into diabetic humans Diabetes Care 32 2009 1887 1889
46. R. Calafiore, G. Basta, G. Luca, A. Lemmi, M.P. Montanucci, G. Calabrese, L. Racanicchi, F. Mancuso, and P. Brunetti Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases Diabetes Care 29 2006 137 138
47. J.E. Bruin, A. Rezania, J. Xu, K. Narayan, J.K. Fox, J.J. O'Neil, and T.J. Kieffer Maturation and function of human embryonic stem cell-derived pancreatic progenitors in macroencapsulation devices following transplant into mice Diabetologia 56 2013 1987 1998
48. E. Motte, E. Szepessy, K. Suenens, G. Stange, M. Bomans, D. Jacobs-Tulleneers-Thevissen, Z. Ling, E. Kroon, and D. Pipeleers Beta Cell Therapy Consortium E-F. Composition and function of macroencapsulated human embryonic stem cell-derived implants: comparison with clinical human islet cell grafts Am. J. Physiol. Endocrinol. Metab. 307 2014 E838 E846
49. F.F. Zhu, P.B. Zhang, D.H. Zhang, X. Sui, M. Yin, T.T. Xiang, Y. Shi, M.X. Ding, and H. Deng Generation of pancreatic insulin-producing cells from rhesus monkey induced pluripotent stem cells Diabetologia 54 2011 2325 2336
50. A.S. Reddi, N. Kothari, K. Kuppasani, and N. Ende Human umbilical cord blood cells and diabetes mellitus: recent advances Curr. Stem Cell Res. Ther. 10 2015 1 ePub
51. P. Fiorina, J. Voltarelli, and N. Zavazava Immunological applications of stem cells in type 1 diabetes Endocr. Rev. 32 2011 725 754
52. P. Yi, J.S. Park, and D.A. Melton Betatrophin A hormone that controls pancreatic beta cell proliferation Cell 153 2013 747 758
53. F. Thorel, V. Nepote, I. Avril, K. Kohno, R. Desgraz, S. Chera, and P.L. Herrera Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss Nature 464 2010 1149 1154
54. Q. Zhou, J. Brown, A. Kanarek, J. Rajagopal, and D.A. Melton In vivo reprogramming of adult pancreatic exocrine cells to beta-cells Nature 455 2008 627 632
55. K. Takahashi, and S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 2006 663 676
56. S. Yamanaka, and H.M. Blau Nuclear reprogramming to a pluripotent state by three approaches Nature 465 2010 704 712
57. K. Okita, Y. Matsumura, Y. Sato, A. Okada, A. Morizane, S. Okamoto, H. Hong, M. Nakagawa, K. Tanabe, K.-i. Tezuka, T. Shibata, T. Kunisada, M. Takahashi, J. Takahashi, H. Saji, and S. Yamanaka A more efficient method to generate integration-free human ips cells Nat. Methods 8 2011 409 412
58. Y. Rais, A. Zviran, S. Geula, O. Gafni, E. Chomsky, S. Viukov, A.A. Mansour, I. Caspi, V. Krupalnik, M. Zerbib, I. Maza, N. Mor, D. Baran, L. Weinberger, D.A. Jaitin, D. Lara-Astiaso, R. Blecher-Gonen, Z. Shipony, Z. Mukamel, T. Hagai, S. Gilad, D. Amann-Zalcenstein, A. Tanay, I. Amit, N. Novershtern, and J.H. Hanna Deterministic direct reprogramming of somatic cells to pluripotency Nature 502 2013 65 70
59. C.A. Sommer, and G. Mostoslavsky The evolving field of induced pluripotency: recent progress and future challenges J. Cell. Physiol. 228 2013 267 275
60. T. Zhao, Z.N. Zhang, Z. Rong, and Y. Xu Immunogenicity of induced pluripotent stem cells Nature 474 2011 212 215
61. K. Okita, N. Nagata, and S. Yamanaka Immunogenicity of induced pluripotent stem cells Circ. Res. 109 2011 720 721
62. R. Araki, M. Uda, Y. Hoki, M. Sunayama, M. Nakamura, S. Ando, M. Sugiura, H. Ideno, A. Shimada, A. Nifuji, and M. Abe Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells Nature 494 2013 100 104
63. M.E. Emborg, Y. Liu, J. Xi, X. Zhang, Y. Yin, J. Lu, V. Joers, C. Swanson, J.E. Holden, and S.C. Zhang Induced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain Cell Rep. 3 2013 646 650
64. Y. Mizukami, T. Abe, H. Shibata, Y. Makimura, S.H. Fujishiro, K. Yanase, S. Hishikawa, E. Kobayashi, and Y. Hanazono Mhc-matched induced pluripotent stem cells can attenuate cellular and humoral immune responses but are still susceptible to innate immunity in pigs PLOS ONE 9 2014 e98319
65. P. Guha, J.W. Morgan, G. Mostoslavsky, N.P. Rodrigues, and A.S. Boyd Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells Cell Stem Cell 12 2013 407 412
66. P.E. de Almeida, E.H. Meyer, N.G. Kooreman, S. Diecke, D. Dey, V. Sanchez-Freire, S. Hu, A. Ebert, J. Odegaard, N.M. Mordwinkin, T.P. Brouwer, D. Lo, D.T. Montoro, M.T. Longaker, R.S. Negrin, and J.C. Wu Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance Nat. Commun. 5 2014 3903
67. A. Morizane, D. Doi, T. Kikuchi, K. Okita, A. Hotta, T. Kawasaki, T. Hayashi, H. Onoe, T. Shiina, S. Yamanaka, and J. Takahashi Direct comparison of autologous and allogeneic transplantation of ipsc-derived neural cells in the brain of a non-human primate Stem Cell Rep. 1 2013 283 292
68. H. Kamao, M. Mandai, S. Okamoto, N. Sakai, A. Suga, S. Sugita, J. Kiryu, and M. Takahashi Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application Stem Cell Rep. 2 2014 205 218
69. T.A. Prokhorova, L.M. Harkness, U. Frandsen, N. Ditzel, H.D. Schroder, J.S. Burns, and M. Kassem Teratoma formation by human embryonic stem cells is site dependent and enhanced by the presence of matrigel Stem Cells Dev. 18 2009 47 54
70. I. Mendez, A. Vinuela, A. Astradsson, K. Mukhida, P. Hallett, H. Robertson, T. Tierney, R. Holness, A. Dagher, J.Q. Trojanowski, and O. Isacson Dopamine neurons implanted into people with parkinson's disease survive without pathology for 14 years Nat. Med. 14 2008 507 509
71. M.E. Emborg, Z. Zhang, V. Joers, K. Brunner, V. Bondarenko, S. Ohshima, and S.C. Zhang Intracerebral transplantation of differentiated human embryonic stem cells to hemiparkinsonian monkeys Cell Transplant. 22 2013 831 838
72. D. Cyranoski Stem cells cruise to clinic Nature 494 2013 413
73. S. Reardon, and D. Cyranoski Japan stem-cell trial stirs envy Nature 513 2014 287 288
74. J. Bloch, Brunet J-FF, C.R. McEntire, and D.E. Redmond Primate adult brain cell autotransplantation produces behavioral and biological recovery in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian st. Kitts monkeys J. Comp. Neurol. 522 2014 2729 2740
75. S.M. Taapken, B.S. Nisler, M.A. Newton, T.L. Sampsell-Barron, K.A. Leonhard, E.M. McIntire, and K.D. Montgomery Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells Nat. Biotechnol. 29 2011 313 314
76. W.T. Nash, J. Teoh, H. Wei, A. Gamache, and M.G. Brown Know thyself: Nk-cell inhibitory receptors prompt self-tolerance, education, and viral control Front. Immunol. 5 2014 175
77. O. Bar-Nur, H.A. Russ, S. Efrat, and N. Benvenisty Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells Cell Stem Cell 9 2011 17 23
78. R. Lister, M. Pelizzola, Y.S. Kida, R.D. Hawkins, J.R. Nery, G. Hon, J. Antosiewicz-Bourget, R. O'Malley, R. Castanon, S. Klugman, M. Downes, R. Yu, R. Stewart, B. Ren, J.A. Thomson, R.M. Evans, and J.R. Ecker Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells Nature 471 2011 68 73
79. M.J. Martin, A. Muotri, F. Gage, and A. Varki Human embryonic stem cells express an immunogenic nonhuman sialic acid Nat. Med. 11 2005 228 232
80. I. Rodriguez-Piza, Y. Richaud-Patin, R. Vassena, F. Gonzalez, M.J. Barrero, A. Veiga, A. Raya, and J.C. Izpisua Belmonte Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions Stem Cells 28 2010 36 44
81. T.L. Chung, J.P. Turner, N.Y. Thaker, G. Kolle, J.J. Cooper-White, S.M. Grimmond, M.F. Pera, and E.J. Wolvetang Ascorbate promotes epigenetic activation of cd30 in human embryonic stem cells Stem Cells 28 2010 1782 1793
82. P.W. Andrews, J. Cavanagro, R. Deans, E. Feigel, E. Horowitz, A. Keating, M. Rao, M. Turner, I. Wilmut, and S. Yamanaka Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells Nat. Biotechnol. 32 2014 724 726
83. N. Trainor, A. Pietak, and T. Smith Rethinking clinical delivery of adult stem cell therapies Nat. Biotechnol. 32 2014 729 735
84. C.J. Taylor, S. Peacock, A.N. Chaudhry, J.A. Bradley, and E.M. Bolton Generating an ipsc bank for hla-matched tissue transplantation based on known donor and recipient hla types Cell Stem Cell 11 2012 147 152
85. F.W. Pagliuca, J.R. Millman, M. Gurtler, M. Segel, A. Van Dervort, J.H. Ryu, Q.P. Peterson, D. Greiner, and D.A. Melton Generation of functional human pancreatic beta cells in vitro Cell 159 2014 428 439
86. F. Vendrame, A. Pileggi, E. Laughlin, G. Allende, A. Martin-Pagola, R.D. Molano, S. Diamantopoulos, N. Standifer, K. Geubtner, B.A. Falk, H. Ichii, H. Takahashi, I. Snowhite, Z. Chen, A. Mendez, L. Chen, J. Sageshima, P. Ruiz, G. Ciancio, C. Ricordi, H. Reijonen, G.T. Nepom, G.W. Burke 3rd, and A. Pugliese Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive cd4 t-cells Diabetes 59 2010 947 957
87. L. Piemonti, M.J. Everly, P. Maffi, M. Scavini, F. Poli, R. Nano, M. Cardillo, R. Melzi, A. Mercalli, V. Sordi, V. Lampasona, A. Espadas de Arias, M. Scalamogna, E. Bosi, E. Bonifacio, A. Secchi, and P.I. Terasaki Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetes Diabetes 62 2013 1656 1664
88. V.A. Huurman, R. Hilbrands, G.G. Pinkse, P. Gillard, G. Duinkerken, P. van de Linde, P.M. van der Meer-Prins, M.F. Versteeg-van der Voort Maarschalk, K. Verbeeck, B.Z. Alizadeh, C. Mathieu, F.K. Gorus, D.L. Roelen, F.H. Claas, B. Keymeulen, D.G. Pipeleers, and B.O. Roep Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation PLoS ONE 3 2008 e2435
89. J.H. Velthuis, W.W. Unger, A.R. van der Slik, G. Duinkerken, M. Engelse, A.F. Schaapherder, J. Ringers, C. van Kooten, E.J. de Koning, and B.O. Roep Accumulation of autoreactive effector t cells and allo-specific regulatory t cells in the pancreas allograft of a type 1 diabetic recipient Diabetologia 52 2009 494 503
90. W.W. Unger, J. Velthuis, J.R. Abreu, S. Laban, E. Quinten, M.G. Kester, S. Reker-Hadrup, A.H. Bakker, G. Duinkerken, A. Mulder, K.L. Franken, R. Hilbrands, B. Keymeulen, M. Peakman, F. Ossendorp, J.W. Drijfhout, T.N. Schumacher, and B.O. Roep Discovery of low-affinity preproinsulin epitopes and detection of autoreactive cd8 t-cells using combinatorial mhc multimers J. Autoimmun. 37 2011 151 159
91. J.H. Velthuis, W.W. Unger, J.R. Abreu, G. Duinkerken, K. Franken, M. Peakman, A.H. Bakker, S. Reker-Hadrup, B. Keymeulen, J.W. Drijfhout, T.N. Schumacher, and B.O. Roep Simultaneous detection of circulating autoreactive cd8+ t-cells specific for different islet cell-associated epitopes using combinatorial mhc multimers Diabetes 59 2010 1721 1730
92. J.R. Abreu, and B.O. Roep Immune monitoring of islet and pancreas transplant recipients Curr. Diabetes Rep. 13 2013 704 712
93. H. Robins Immunosequencing applications of immune repertoire deep sequencing Curr. Opin. Immunol. 25 2013 646 652
94. R.P. Robertson, K.J. Lanz, D.E. Sutherland, and D.M. Kendall Prevention of diabetes for up to 13 years by autoislet transplantation after pancreatectomy for chronic pancreatitis Diabetes 50 2001 47 50
95. M. Dong, A.K. Parsaik, P.J. Erwin, M.B. Farnell, M.H. Murad, and Y.C. Kudva Systematic review and meta-analysis: islet autotransplantation after pancreatectomy for minimizing diabetes Clin. Endocrinol. (Oxf.) 75 2011 771 779
96. K. Bramis, A.N. Gordon-Weeks, P.J. Friend, E. Bastin, A. Burls, M.A. Silva, and A.R. Dennison Systematic review of total pancreatectomy and islet autotransplantation for chronic pancreatitis Br. J. Surg. 99 2012 761 766
97. T.L. van Belle, K.T. Coppieters, and M.G. von Herrath Type 1 diabetes: etiology, immunology, and therapeutic strategies Physiol. Rev. 91 2011 79 118
98. A.G. Ziegler, M. Rewers, O. Simell, T. Simell, J. Lempainen, A. Steck, C. Winkler, J. Ilonen, R. Veijola, M. Knip, E. Bonifacio, and G.S. Eisenbarth Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children JAMA 309 2013 2473 2479
99. G.W. Burke 3rd, F. Vendrame, A. Pileggi, G. Ciancio, H. Reijonen, and A. Pugliese Recurrence of autoimmunity following pancreas transplantation Curr. Diabetes Rep. 11 2011 413 419
100. P. Concannon, S.S. Rich, and G.T. Nepom Genetics of type 1a diabetes N. Engl. J. Med. 360 2009 1646 1654
101. S. Brouard, A. Le Bars, A. Dufay, M. Gosselin, Y. Foucher, M. Guillet, A. Cesbron-Gautier, E. Thervet, C. Legendre, E. Dugast, A. Pallier, C. Guillot-Gueguen, L. Lagoutte, G. Evanno, M. Giral, and J.P. Soulillou Identification of a gene expression profile associated with operational tolerance among a selected group of stable kidney transplant patients Transpl. Int. 24 2011 536 547
102. S. Heidt, and K.J. Wood Biomarkers of operational tolerance in solid organ transplantation Exp. Opin. Med. Diagn. 6 2012 281 293
103. M. Goldman, and K. Wood Transplantation research: will we ever reach the holy grail Transplantation 87 2009 S99 S100
104. J.H. Helderman, and S. Goral Transplantation for the millennium: attaining tolerance in our time - the holy grail Semin. Nephrol. 20 2000 83 86
105. L. Zhao, T. Teklemariam, and B.M. Hantash Heterelogous expression of mutated hla-g decreases immunogenicity of human embryonic stem cells and their epidermal derivatives Stem Cell Res. 13 2014 342 354
106. Z. Rong, M. Wang, Z. Hu, M. Stradner, S. Zhu, H. Kong, H. Yi, A. Goldrath, Y.-G.G. Yang, Y. Xu, and X. Fu An effective approach to prevent immune rejection of human esc-derived allografts Cell Stem Cell 14 2014 121 130
107. H. Arefanian, E.B. Tredget, R.V. Rajotte, R.G. Gill, G.S. Korbutt, and G.R. Rayat Short-term administrations of a combination of anti-lfa-1 and anti-cd154 monoclonal antibodies induce tolerance to neonatal porcine islet xenografts in mice Diabetes 59 2010 958 966
108. P. Thompson, K. Cardona, M. Russell, I.R. Badell, V. Shaffer, G. Korbutt, G.R. Rayat, J. Cano, M. Song, W. Jiang, E. Strobert, R. Rajotte, T. Pearson, A.D. Kirk, and C.P. Larsen Cd40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates Am. J. Transpl. 11 2011 947 957
109. A.M. Posselt, M.D. Bellin, M. Tavakol, G.L. Szot, L.A. Frassetto, U. Masharani, R.K. Kerlan, L. Fong, F.G. Vincenti, B.J. Hering, J.A. Bluestone, and P.G. Stock Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-lfa-1 antibody efalizumab Am. J. Transpl. 10 2010 1870 1880
110. G.L. Szot, M. Yadav, J. Lang, E. Kroon, J. Kerr, K. Kadoya, E.P. Brandon, E.E. Baetge, H. Bour-Jordan, and J.A. Bluestone Tolerance induction and reversal of diabetes in mice transplanted with human embryonic-stem-cell-derived pancreatic endoderm Cell Stem Cell 16 2015 148 157
111. A. Vergani, F. D'Addio, M. Jurewicz, A. Petrelli, T. Watanabe, K. Liu, K. Law, C. Schuetz, M. Carvello, E. Orsenigo, S. Deng, S.J. Rodig, J.M. Ansari, C. Staudacher, R. Abdi, J. Williams, J. Markmann, M. Atkinson, M.H. Sayegh, and P. Fiorina A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in nod mice Diabetes 59 2010 2253 2264
112. B.O. Roep, and T.I. Tree Immune modulation in humans: implications for type 1 diabetes mellitus Nat. Rev. Endocrinol. 10 2014 229 242
113. C.E. Couri, M.C. Oliveira, A.B. Stracieri, D.A. Moraes, F. Pieroni, G.M. Barros, M.I. Madeira, K.C. Malmegrim, M.C. Foss-Freitas, B.P. Simoes, E.Z. Martinez, M.C. Foss, R.K. Burt, and J.C. Voltarelli C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus JAMA 301 2009 1573 1579
114. P.O. Carlsson, E. Schwarcz, O. Korsgren, and K. Le Blanc Preserved beta-cell function in type 1 diabetes by mesenchymal stromal cells Diabetes 64 2015 587 592
115. M. von Herrath, M. Peakman, and B. Roep Progress in immune-based therapies for type 1 diabetes Clin. Exp. Immunol. 172 2013 186 202
116. M. Ben Nasr, F. D'Addio, V. Usuelli, S. Tezza, R. Abdi, and P. Fiorina The rise, fall, and resurgence of immunotherapy in type 1 diabetes Pharmacol. Res. 2014 (6 August) ePub
117. Y. Jiao, J. Le Lay, M. Yu, A. Naji, and K.H. Kaestner Elevated mouse hepatic betatrophin expression does not increase human β-cell replication in the transplant setting Diabetes 63 2014 1283 1288
118. A.F. Stewart Betatrophin versus bitter-trophin and the elephant in the room: time for a new normal in β-cell regeneration research Diabetes 63 2014 1198 1199